Skip to content
Screener

Harrow HROW EPS (Basic)

EPS (Basic) at other companies

AbbVie logo
AbbVieABBV
$0.39-45.8%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$0.06+200%
Bausch + Lomb logo
Bausch + LombBLCO
-$0.04+77.8%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
-$0.40-5.3%
Opko Health logo
Opko HealthOPK
-$0.01+94.7%
Bausch Health Companies logo
Bausch Health CompaniesBHC
-$3.82-2,287%

Other financials

Income statement

See full
Revenue$44.2M-7.6%
Gross profit$27.0M-16.3%
Operating income-$22.1M-96.6%
Net income-$27.6M-55.2%
EPS (diluted)-$0.74-48.0%

Balance sheet

See full
Cash & equivalents$94.6M+41.8%
Total debt$308.6M-32.9%
Total equity$28.7M-49.1%
Total assets$419.5M+15.2%

Cash flow

See full
Operating cash flow-$9.0M-146%
CapEx$194.0K+14.1%
Free cash flow-$9.2M-147%

Valuation

See full
Market cap$1.49B+22.8%
Enterprise value$1.7B+5.6%
P/S5.5×+0.2×

Profitability

See full
Gross margin74.1%-0.4pp
Operating margin7.3%+5.2pp
Net margin-19.8%+18.0pp
FCF margin5.7%+5.0pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity10.7×+2.6×
Current ratio2.5×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.

The source filing: Harrow’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 4:31 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001493152-26-022254
Line item2026 / For the Three Months Ended March 31,2025 / For the Three Months Ended March 31,
Total operating expenses49,125,00043,539,000
Loss from operations(22,080,000)(11,232,000)
Interest expense, net(5,497,000)(6,548,000)
Loss before income taxes(27,577,000)(17,780,000)
Income tax expense(25,000)-
Net loss$(27,602,000)$(17,780,000)
Basic and diluted net loss per share of common stock$(0.74)$(0.50)
Weighted average number of shares of common stock outstanding, basic and diluted37,231,32135,826,452

Item 1. Financial Statements (unaudited) Item

FAQ

What is Harrow's EPS (basic)?
Harrow (HROW) reported EPS (basic) of -$0.74 in Q1 2026.
How has Harrow's EPS (basic) changed year-over-year?
Harrow's EPS (basic) decreased by 48.0% year-over-year, from -$0.50 to -$0.74.
What is the long-term trend for Harrow's EPS (basic)?
Over 2 years (2021 to 2023), Harrow's EPS (basic) has grown at a 5.7% compound annual growth rate (CAGR), from -$0.68 to -$0.76.
What does EPS (basic) mean?
Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.

Ask your AI about Harrow's eps (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude